HUAREN MEDICAL TECHNOLOGY
NEWS
Company News
08
2022-05
Cancer Cell: Inflammatory fibroblasts reduce radiotherapy sensitivity in rectal cancer
Colorectal cancer is one of the most common cancers worldwide and has the second highest mortality rate among malignant tumours. Treatment options for patients with colorectal cancer include surgery, chemotherapy, radiotherapy and other molecularly targeted strategies that significantly prolong patient survival. Among colorectal cancers, rectal cancers have a worse prognosis than colon cancers in terms of both metastasis formation and local recurrence.
View More26
2022-04
![[Lianhua Plague Dispute] - Please let science return to science.](https://omo-oss-image.thefastimg.com/portal-saas/pg2025032818250822643/cms/image/b43b3f3c-7557-42a0-b516-d0750f28fb2f.jpg "[Lianhua Plague Dispute] - Please let science return to science.")
[Lianhua Plague Dispute] - Please let science return to science.
For a long time, Shanghai for many consecutive days, the number of new new crown pneumonia infections over 10,000, the main epidemic strain of this outbreak is omikujon BA.2, has a fast transmission speed, invisibility, asymptomatic and a high proportion of mild symptoms, based on the population density of Shanghai, the difficulty of prevention and control is much higher than ever before.
View More26
2022-04
Genetic testing, a game changer
Do you wish to foretell tomorrow, or do you prefer to be ready for the surprises or scares that fate gives you? With genetic testing, we will have the language of life. Know your enemy, know yourself, and seize the opportunity to control your destiny!
View More16
2022-04
Vigilance! New Coronavirus May Cause Male Reproductive Damage
In January 2020, academician Zhong Nanshan suggested that the new coronavirus had appeared as a human-to-human transmission phenomenon, and since then, our lives have changed drastically, as the new coronavirus has caused devastation around the world, and people's lives have come to a halt for a while. Until the end of 2020, the launch of the new coronavirus vaccine gave people hope to defeat the virus.
View More16
2022-04
On April 14, 2022, Ji Feng, president of Guangxi Academy of Sciences Institute of Medicine and Health, and his party visited Guangxi International Zhuang Medical Hospital and carried out a symposium, which was attended by Yue Guihua, president of Guangxi International Zhuang Medical Hospital, and Huang Guodong, vice president of Guangxi International Zhuang Medical Hospital.
View More16
2022-04
NK cells can be used in consolidation therapy for multiple myeloma
To date, multiple myeloma remains an incurable disease and autologous haematopoietic stem cell transplantation is one of the mainstays of treatment, often followed by long-term maintenance therapy with immunomodulators or proteasome inhibitors. However, due to the average age of patients receiving a diagnosis of 65-70 years, the use of autologous HSCT therapy to achieve long-term control of disease progression is not realistic. In addition, there are many serious side effects associated with the long-term use of maintenance therapy, including the risk of haematopenia, thrombosis, secondary malignancy and neuropathy. A promising approach is the use of alternative cell therapy as consolidation after autologous HSCT, which does not have the side effects of maintenance therapy.
View MoreSUBSCRIPTION INFORMATION
We will send you real-time information regularly!
Guangxi Huaren Medical Technology Group Co., Ltd.
Tel: 400-138-8669/ 0771-611-0603
Address: 15th Floor, Building A, Biyuan Center, Wuxiang New District, Nanning City, China (Guangxi) Pilot Free Trade Zone
Huaren Medical Technology
Huaren Medical Research
Hua Ren Cell said